Form 4: Abeona Therapeutics Director Sells Shares to Cover Tax Obligations
SEC Form 4
Christine Berni Silverstein, a director of Abeona Therapeutics, sold shares of common stock to cover tax obligations associated with the vesting of restricted stock awards.
Summary
- On June 18, 2024, Christine Berni Silverstein, a director of Abeona Therapeutics Inc., sold 25,821 shares of common stock.
- The sale was executed to cover tax obligations related to the vesting of restricted stock awards.
- The shares were sold at a weighted average price of $4.51, with individual transactions ranging from $4.47 to $4.55.
- Following the transaction, Silverstein directly owns 62,063 shares of Abeona Therapeutics Inc.
Sentiment
Score: 5
Explanation: The document reports a routine stock sale by a director to cover tax obligations, which is neither particularly positive nor negative.
Industry Context
Sales by company directors are a normal part of corporate governance. It is important to consider the context of the sale, in this case to cover tax obligations, when assessing the impact on the company's stock.
Stakeholder Impact
- The sale of shares by a director could have a minor impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 06/17/2024 | Date of Earliest Transaction |
| 06/18/2024 | Transaction Date: Sale of Common Stock |
| 06/20/2024 | Date of Signature |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.